HIGHLIGHTS
- who: Coptisine et al. from the Mahasarakham University, Thailand have published the paper: Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis, in the Journal: (JOURNAL) of 25/06/2022
- what: In the present study, the biotargets, functional processes and molecular frontiersin.org 10.3389/fphar.2022.1037856 Firstly, the authors investigated the phytochemicals that meet the criteria of OB u2265 30% and DL u2265 0.18, which were regarded as the active components.
- how: The results indicated that Coptisine as well as Berberine . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.